Abstract:The poor prognosis of cancer and other diseases has often been linked to challenges pertaining to drug accessibility and delivery. To combat these challenges, nanotechnology has witnessed decades of intensive research, resulting in the development of innovative nanoscale strategies for improving therapies and minimizing the side effects of existing drugs. Notably, multiple nanocarriers have obtained clinical approval as proficient drug delivery systems. Metal-organic frameworks (MOFs) have emerged as an interesting paradigm owing to their tuneable porosity, structural diversity, and ease of external surface functionalization. Compared to other drug delivery systems, state-of-the-art MOFs can encapsulate up to 50 times higher quantities of drugs per unit of mass while showing very long release times. Nevertheless, for their translation into clinical applications, concerns regarding MOF biocompatibility necessitate comprehensive mitigation. Unfortunately, experiments are resource and time-intensive, while modeling approaches fail to capture the behavior of MOFs in intricate biological systems. To overcome these barriers, we review here recent advances on biocompatibility and propose a novel computational pipeline guided by machine learning (ML). This is designed to expedite the assessment of potential MOF toxicity based on the chemical properties of their precursors. Interpretable ML models were built on a database of over 35,000 organic molecules, predicting the potential toxicity of MOF linkers with 83% accuracy. Additionally, we established a comprehensive database cataloging the toxicity of MOF metallic centers. Leveraging these, we have screened the Cambridge Structural Database (CSD) containing 86,000 non-disordered MOFs, identifying existing and future promising candidates with minimal toxicity profiles for drug delivery applications. Beyond high-throughput screening, the developed models shed light on the chemical landscape associated with high biocompatibility precursor molecules, enabling the derivation of guidelines for the rational design of biocompatible MOFs. This framework thus expedites the identification of biocompatible materials, while facilitating deeper insights into their underlying chemistry. The protocols developed here will be easily transferred to other systems, accelerating associated research timescales.

Synergistic Machine Learning Accelerated Discovery of Nanoporous Inorganic Crystals as Non‐Absorbable Oral Drugs

Archaea-Inspired Switchable Nanochannels for On-Demand Lithium Detection by pH Activation

Polytonic Drug Release via Multi-Hierarchical Microstructures Enabled by Nano-Metamaterials

Guiding the rational design of biocompatible metal-organic frameworks for drug delivery using machine learning

A large-scale machine learning analysis of inorganic nanoparticles in preclinical cancer research

Computer-aided nanodrug discovery: recent progress and future prospects

Automated discovery of nanomaterials via drug aggregation induced emission

Nanonitrator: novel enhancer of inorganic nitrate’s protective effects, predicated on swarm learning approach

Pharmacophore Hybridisation and Nanoscale Assembly to Discover Self-Delivering Lysosomotropic New-Chemical Entities for Cancer Therapy

Integration of Polymerization and Biomineralization As a Strategy to Facilely Synthesize Nanotheranostic Agents

Nanoarchitectured Structure and Surface Biofunctionality of Mesoporous Silica Nanoparticles

In Situ Biomimetic Mineralization on ZIF-8 for Smart Drug Delivery

A Biodegradable Nano-Drug Delivery Platform for Co-Delivery of Minocycline and Chitosan to Achieve Efficient and Safe Non-Surgical Periodontitis Therapy

On the additive artificial intelligence-based discovery of nanoparticle neurodegenerative disease drug delivery systems

Drug-mediation Formation of Nanohybrids for Sequential Therapeutic Delivery in Cancer Cells.

Expediting carbon dots synthesis by the active adaptive method with machine learning and applications in dental diagnosis and treatment

Synthesis and Characterization of Dual Radiolabeled Layered Double Hydroxide Nanoparticles for Use in In Vitro and In Vivo Nanotoxicology Studies

Accelerating reliable multiscale quantum refinement of protein-drug systems enabled by machine learning

Near-Infrared Mechanoluminescence from Cr3+-Doped Spinel Nanoparticles for Potential Oral Diseases Detection

Hybrid drug nanocrystals.

Nanoscale Metal−Organic Frameworks and Their Nanomedicine Applications